VolitionRX Limited Common Stock (VNRX)

About VNRX

VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes. It also provide…

Sector

Health Care

Industry

Biotechnology: In Vitro & In Vivo Diagnostic Substances

Employees

57

Website

volition.com/

Fundamentals

1-day range

$0.501$0.72

Market cap

$9.23M

P/E (trailing)

—

P/E (forward)

-0.59

EPS (trailing)

$-4.22

Dividend yield

—

Beta

1.14

Avg. volume

7.14M

Forecasts

5 analyst ratings

VolitionRX Limited Common Stock Competitors

Chosen by industry and closest market cap.

• VNRX

  VolitionRX Limited Common Stock

  $0.45

  ▼ 10.00%
  Market cap $9.23MP/E —
  $0.3269$14.8
• BMRA

  Biomerica Inc. Common Stock

  $2.14

  ▲ 1.67%
  Market cap $4.94MP/E —
  $1.45$3.31
• CDIO

  Cardio Diagnostics Holdings Inc. Common stock

  $1.84

  ▼ 1.60%
  Market cap $4.91MP/E —
  $0.97$7.91
• QCLS

  Q/C Technologies Inc. Common Stock

  $2.37

  ▲ 0.00%
  Market cap $21.99MP/E —
• IMDX

  Insight Molecular Diagnostics Inc. Common Stock

  $4.16

  ▼ 3.03%
  Market cap $154.99MP/E —
  $2.33$8.51
• TKNO

  Alpha Teknova Inc. Common Stock

  $7.13

  ▼ 2.46%
  Market cap $350.10MP/E —
  $1.91$7.84
• ACHV

  Achieve Life Sciences Inc. Common Shares

  $8.09

  ▼ 1.16%
  Market cap $672.42MP/E —
  $2.62$8.61

P/E shows — for peers not currently carrying a live signal of their own.